Related Experiment Videos
Summary
Non-psychiatrist physicians can manage anxiety by identifying medical causes and using supportive psychotherapy, behavioral therapies, and short-term medication. Benzodiazepines are common, but new non-addictive options like buspirone show promise.
Area of Science:
- General Medicine
- Psychiatry
- Pharmacology
Background:
- Anxiety is a common symptom with diverse potential causes.
- Non-psychiatrist physicians often encounter patients experiencing anxiety.
- Accurate diagnosis is crucial for effective anxiety management.
Purpose of the Study:
- To guide non-psychiatrist physicians in diagnosing and treating anxiety symptoms.
- To outline differential diagnoses for anxiety.
- To review current and emerging pharmacotherapeutic options for anxiety.
Main Methods:
- Review of potential medical and psychiatric causes of anxiety.
- Discussion of diagnostic exclusion for situational anxiety.
- Overview of treatment modalities including psychotherapy and pharmacotherapy.
Main Results:
- Anxiety can stem from medical disorders, substance use, or primary psychiatric conditions.
- Treatment typically involves education, psychotherapy, behavioral techniques, and pharmacotherapy.
- Benzodiazepines are primary pharmacotherapy, selected by pharmacokinetic and side-effect profiles.
- Buspirone, a nonbenzodiazepine, shows potential for efficacy and safety.
Conclusions:
- A systematic approach guided by common sense is recommended for non-psychiatrist physicians managing anxiety.
- Current pharmacotherapy relies heavily on benzodiazepines, with careful selection based on patient factors.
- Emerging nonbenzodiazepine agents like buspirone warrant further investigation for anxiety treatment.